- Release Date: 27/06/25 09:01
- Summary: First Surgical Use of Remplir in US$1.6 Billion US Market
- Price Sensitive: Yes
- Download Document 211.85KB
- Forums
- ASX - By Stock
- OCC
- Ann: First Surgical Use of Remplir in US$1.6 Billion US Market
OCC
orthocell limited
Add to My Watchlist
6.19%
!
$1.20

Ann: First Surgical Use of Remplir in US$1.6 Billion US Market
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.20 |
Change
0.070(6.19%) |
Mkt cap ! $291.8M |
Open | High | Low | Value | Volume |
$1.16 | $1.21 | $1.15 | $758.9K | 641.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 2757 | $1.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.20 | 27776 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 4126 | 1.195 |
9 | 14051 | 1.190 |
4 | 7068 | 1.185 |
6 | 91541 | 1.180 |
5 | 22259 | 1.175 |
Price($) | Vol. | No. |
---|---|---|
1.200 | 27682 | 11 |
1.205 | 46304 | 4 |
1.210 | 4339 | 4 |
1.215 | 1505 | 2 |
1.220 | 42545 | 4 |
Last trade - 12.34pm 08/09/2025 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |
The Watchlist
PSC
PROSPECT RESOURCES LIMITED
Sam Hosack, MD & CEO
Sam Hosack
MD & CEO
SPONSORED BY The Market Online